{"id":"W3134278412","doi":"10.1111/jdv.17218","title":"Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Galderma","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Placebo; Post-hoc analysis; Clinical endpoint; Internal medicine; Randomized controlled trial; Adverse effect; Gastroenterology; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002831602,0.001036331,0.002206287,0.0002750281,0.0002509998,0.0008304303,0.0004799901,0.0008882547,0.003785276],"category_scores_gemma":[0.00148152,0.0004757486,0.001827963,0.0002487231,0.0004027825,0.0005401992,0.0003420295,0.001569351,0.000682247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003930263,"about_ca_system_score_gemma":0.0006683242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002624514,"about_ca_topic_score_gemma":0.000823303,"domain_scores_codex":[0.9990878,0.0005420247,0.00005991631,0.0001243112,0.00009598177,0.00008991963],"domain_scores_gemma":[0.9990286,0.0002067671,0.000294699,0.0001393694,0.00007581992,0.000254734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9376972,0.008341995,0.007494176,0.000473093,0.002666283,0.000104662,0.00006597232,0.0003650362,0.01781368,0.00005330886,0.001206592,0.02371798],"study_design_scores_gemma":[0.7141525,0.2179557,0.06059583,0.00005504476,0.002041606,0.0002608101,0.00004179717,0.0005781102,0.002133507,0.0001173532,0.002034448,0.00003340487],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946998,0.001929224,0.0003101284,0.0002049448,0.00008017279,0.001099329,0.0007744956,0.00005726752,0.0008446251],"genre_scores_gemma":[0.9918448,0.001046051,0.00102211,0.0004979407,0.0001989402,0.001754237,0.001603833,0.00003256853,0.001999505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003785276,"threshold_uncertainty_score":0.01497513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01513282737951529,"score_gpt":0.2887306334420211,"score_spread":0.2735978060625058,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}